Herbal Medicine Nanocrystals: A Potential Novel Therapeutic Strategy

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2023 Sep 9

PMID 37687199

Authors

Mengran Guo

Shugang Qin

Shiyan Wang

Min Sun

Huiling Yang

Xinchun Wang

Ping Fan

Zhaohui Jin

Affiliations

Soon will be listed here.

Abstract

Herbal medicines have gained recognition among physicians and patients due to their lower adverse effects compared to modern medicines. They are extensively used to treat various diseases, including cancer, cardiovascular issues, chronic inflammation, microbial contamination, diabetes, obesity, and hepatic disorders, among others. Unfortunately, the clinical application of herbal medicines is limited by their low solubility and inadequate bioavailability. Utilizing herbal medicines in the form of nanocrystals (herbal medicine nanocrystals) has shown potential in enhancing solubility and bioavailability by reducing the particle size, increasing the specific surface area, and modifying the absorption mechanisms. Multiple studies have demonstrated that these nanocrystals significantly improve drug efficacy by reducing toxicity and increasing bioavailability. This review comprehensively examines therapeutic approaches based on herbal medicine nanocrystals. It covers the preparation principles, key factors influencing nucleation and polymorphism control, applications, and limitations. The review underscores the importance of optimizing delivery systems for successful herbal medicine nanocrystal therapeutics. Furthermore, it discusses the main challenges and opportunities in developing herbal medicine nanocrystals for the purpose of treating conditions such as cancer, inflammatory diseases, cardiovascular disorders, mental and nervous diseases, and antimicrobial infections. In conclusion, we have deliberated regarding the hurdles and forthcoming outlook in the realm of nanotoxicity, in vivo kinetics, herbal ingredients as stabilizers of nanocrystals, and the potential for surmounting drug resistance through the utilization of nanocrystalline formulations in herbal medicine. We anticipate that this review will offer innovative insights into the development of herbal medicine nanocrystals as a promising and novel therapeutic strategy.

Citing Articles

Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects.

Seo S, Kim G, Kim M, Lee K, Kim M, Chaudhary M Pharmaceutics. 2024; 16(8).

PMID: 39204378 PMC: 11359960. DOI: 10.3390/pharmaceutics16081033.

Enhanced Anti-Inflammatory Activity of Tilianin Based on the Novel Amorphous Nanocrystals.

Sun M, Guo M, He Z, Luo Y, He X, Huang C Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794224 PMC: 11125044. DOI: 10.3390/ph17050654.

Herbal Nanoformulations for Diabetes: Mechanisms, Formulations, and Clinical Impact.

Sunita , Kaushik R, Verma K, Parveen R Curr Diabetes Rev. 2024; 21(3):68-85.

PMID: 38500279 DOI: 10.2174/0115733998288592240308073925.

Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes.

Olla S, Siguri C, Fais A, Era B, Fantini M, Di Petrillo A Int J Mol Sci. 2023; 24(20).

PMID: 37895071 PMC: 10607112. DOI: 10.3390/ijms242015391.

References

Huang X, Zhu H . Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med Chem. 2011; 11(5):479-90. DOI: 10.2174/187152011795677427. View

Zhang G, Wang Y, Zhang Z, He Z, Liu Y, Fu Q . FRET imaging revealed that nanocrystals enhanced drug oral absorption by dissolution rather than endocytosis: A case study of coumarin 6. J Control Release. 2021; 332:225-232. DOI: 10.1016/j.jconrel.2021.02.025. View

Zheng D, Wang Y, Zhang D, Liu Z, Duan C, Jia L . In vitro antitumor activity of silybin nanosuspension in PC-3 cells. Cancer Lett. 2011; 307(2):158-64. DOI: 10.1016/j.canlet.2011.03.028. View

Lou H, Gao L, Wei X, Zhang Z, Zheng D, Zhang D . Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice. Colloids Surf B Biointerfaces. 2011; 87(2):319-25. DOI: 10.1016/j.colsurfb.2011.05.037. View

Li R, Wang L, Duan H, Zhang Q, Guo X, Wu C . Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases. Front Pharmacol. 2022; 13:937289. PMC: 9535092. DOI: 10.3389/fphar.2022.937289. View

Yao Z, Wang W, Ning J, Zhang X, Zheng W, Qian Y . Hydroxycamptothecin Inhibits Peritendinous Adhesion the Endoplasmic Reticulum Stress-Dependent Apoptosis. Front Pharmacol. 2019; 10:967. PMC: 6737834. DOI: 10.3389/fphar.2019.00967. View

Bian P, Hu W, Liu C, Li L . Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved. Arch Biochem Biophys. 2020; 689:108461. DOI: 10.1016/j.abb.2020.108461. View

Sarkari M, Brown J, Chen X, Swinnea S, Williams 3rd R, Johnston K . Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int J Pharm. 2002; 243(1-2):17-31. DOI: 10.1016/s0378-5173(02)00072-8. View

Ng C, Yu L, Ong C, Bay B, Baeg G . The use of as a model organism to study immune-nanotoxicity. Nanotoxicology. 2018; 13(4):429-446. DOI: 10.1080/17435390.2018.1546413. View

10.

Zhang B, Lung P, Zhao S, Chu Z, Chrzanowski W, Li Q . Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells. Sci Rep. 2017; 7(1):7315. PMC: 5544670. DOI: 10.1038/s41598-017-07588-9. View

11.

Khanna P, Ong C, Bay B, Baeg G . Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death. Nanomaterials (Basel). 2017; 5(3):1163-1180. PMC: 5304638. DOI: 10.3390/nano5031163. View

12.

Rui T, Zhang L, Qiao H, Huang P, Qian S, Li J . Preparation and Physicochemical and Pharmacokinetic Characterization of Ginkgo Lactone Nanosuspensions for Antiplatelet Aggregation. J Pharm Sci. 2016; 105(1):242-9. DOI: 10.1016/j.xphs.2015.10.002. View

13.

Li Y, Sun S, Chang Q, Zhang L, Wang G, Chen W . A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals. Mol Pharm. 2013; 10(7):2534-42. DOI: 10.1021/mp300688t. View

14.

Chen T, Li C, Li Y, Yi X, Lee S, Zheng Y . Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease. Mol Pharm. 2016; 13(11):3864-3875. DOI: 10.1021/acs.molpharmaceut.6b00644. View

15.

Lai F, Pireddu R, Corrias F, Fadda A, Valenti D, Pini E . Nanosuspension improves tretinoin photostability and delivery to the skin. Int J Pharm. 2013; 458(1):104-9. DOI: 10.1016/j.ijpharm.2013.10.007. View

16.

Sun M, Gao Y, Pei Y, Guo C, Li H, Cao F . Development of nanosuspension formulation for oral delivery of quercetin. J Biomed Nanotechnol. 2011; 6(4):325-32. DOI: 10.1166/jbn.2010.1133. View

17.

Shelar D, Pawar S, Vavia P . Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability. Drug Deliv Transl Res. 2015; 3(5):384-91. DOI: 10.1007/s13346-012-0081-3. View

18.

Giordano A, Tommonaro G . Curcumin and Cancer. Nutrients. 2019; 11(10). PMC: 6835707. DOI: 10.3390/nu11102376. View

19.

Lindfors L, Forssen S, Westergren J, Olsson U . Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interface Sci. 2008; 325(2):404-13. DOI: 10.1016/j.jcis.2008.05.034. View

20.

Zhou W, Zhang Y, Li R, Peng S, Ruan R, Li J . Fabrication of Caseinate Stabilized Thymol Nanosuspensions via the pH-Driven Method: Enhancement in Water Solubility of Thymol. Foods. 2021; 10(5). PMC: 8151133. DOI: 10.3390/foods10051074. View